Clinical Trials Directory

Trials / Completed

CompletedNCT02331537

Internet-based Exposure Therapy for Excessive Worry

Internet-based Exposure Therapy for Excessive Worry: A Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Karolinska Institutet · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine if an internet-based exposure therapy is effective in reducing excessive worry amongst patients who suffer from this problem.

Detailed description

Trial Objectives: Primary objective is to investigate whether an Internet-based exposure therapy can effectively reduce the degree of excessive worry. The secondary objective is to a) investigate whether imagery based exposure is more effective than verbal exposure. b) investigate the cost-effectiveness of this treatment and c) to study if any variables could moderate/mediate the treatment outcome, such as metacognitions, degree of rumination or degree of depression. Trial Design: Randomized controlled trial with waitlist control, who also will recieve treatment after the first group has finished. Duration: Ten weeks Primary Endpoint: Change in worry symptoms from baseline to Week 10. Long term follow-up is also investigated (baseline to 4-months after treatment completion and baseline to 12-months after treatment completion). Efficacy Parameters: Penn State Worry Questionnaire (PSWQ) Safety Parameters: Adverse Events is assessed weekly via the internet. Description of Trial Subjects: Patients \> 18 years old with a PSWQ score more than 56 points Number of Subjects: 140

Conditions

Interventions

TypeNameDescription
BEHAVIORALInternet-based cognitive-behavior therapyInternet-based cognitive-behavior therapy on a safe internet platform. Treatment is divided into seven modules, each containing homework assignments . The participants will be assigned a therapist that they can contact through a message system in the platform and expect answer within 24 hours.

Timeline

Start date
2015-01-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-01-06
Last updated
2015-09-01

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02331537. Inclusion in this directory is not an endorsement.